Siatis Perry C Insider Trades at AbbVie Inc.

Spot the Money

Siatis Perry C

EVP, GC AND SECRETARY at AbbVie Inc.

Company: AbbVie Inc.
Ticker: ABBV
First filing on record: February 20, 2026
Latest trade on record: March 2, 2026
SEC filings: EDGAR ↗

Siatis Perry C, EVP, GC AND SECRETARY at AbbVie Inc., has disclosed 16 transactions in ABBV since February 20, 2026: 0 purchases (0 open-market buys) and 5 sales, worth about $20.7M at the reported prices. The latest was filed March 3, 2026, 1 day after the trade.

Last updated March 3, 2026 · Source: SEC EDGAR Form 4 filings

Transactions

16

Open-market buys

0

Sales

5

Avg. disclosure lag

1.9d

Trading in charts

Trade timeline

When does this person trade, how big, and in which direction? Every trade in the last 12 months.

Bought (above the line)Sold (below the line)Other transaction

In the last 12 months Siatis Perry C made no purchases and 5 sales worth $13M, plus 11 other transactions. Dot size is the dollar amount.

Portfolio mix

Which stocks does this person trade most? Tile size is dollars traded, all time on record.

Siatis Perry C has traded 1 stock on record; the largest by dollars is ABBV.

Reporting lag

Does this person report on time? One bar per filing against the Form 4 deadline.

On timeLate

0 of 3 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).

What kind of transactions

Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.

Rows by Form 4 transaction code
Code	Meaning	Rows	Shares	Value
M	Option exercise or conversion	6	44,762	$7.7M
A	Grant or award	5	53,018	—
S	Open-market sale	4	41,049	$9.5M
F	Shares withheld for tax	1	14,850	$3.4M

Rows by year of the trade
Year	Rows	Bought	Sold
2026	16	0	5 · $13.0M

Transactions

Download ABBV trades (CSV)102 rows · 33 KB · every filer in this ticker, this insider included · all downloads

Security	Side	Trade date	Disclosed	Lag	Shares	Price	Value	Flags	Source
ABBV	Sell S	March 2, 2026	March 3, 2026	1d	2,600	$235	$612K	10b5-1 plan	Form 4 ↗
ABBV	Sell S	March 2, 2026	March 3, 2026	1d	10,291	$235	$2.4M	10b5-1 plan	Form 4 ↗
ABBV	Sell S	March 2, 2026	March 3, 2026	1d	5,777	$234	$1.3M	10b5-1 plan	Form 4 ↗
ABBV	Sell F	February 27, 2026	March 3, 2026	4d	14,850	$232	$3.4M	10b5-1 plan	Form 4 ↗
ABBV	Option / conversion M	February 25, 2026	February 27, 2026	2d	7,292	$193	$1.4M	10b5-1 plan derivative	Form 4 ↗
ABBV	Option / conversion M	February 25, 2026	February 27, 2026	2d	7,775	$175	$1.4M	10b5-1 plan derivative	Form 4 ↗
ABBV	Option / conversion M	February 25, 2026	February 27, 2026	2d	7,314	$150	$1.1M	10b5-1 plan derivative	Form 4 ↗
ABBV	Sell S	February 25, 2026	February 27, 2026	2d	22,381	$230	$5.1M	10b5-1 plan	Form 4 ↗
ABBV	Option / conversion M	February 25, 2026	February 27, 2026	2d	7,292	$193	$1.4M	10b5-1 plan	Form 4 ↗
ABBV	Option / conversion M	February 25, 2026	February 27, 2026	2d	7,775	$175	$1.4M	10b5-1 plan	Form 4 ↗
ABBV	Option / conversion M	February 25, 2026	February 27, 2026	2d	7,314	$150	$1.1M	10b5-1 plan	Form 4 ↗
ABBV	Other A	February 18, 2026	February 20, 2026	2d	19,500	—	—	derivative	Form 4 ↗
ABBV	Other A	February 18, 2026	February 20, 2026	2d	5,808	—	—		Form 4 ↗
ABBV	Other A	February 18, 2026	February 20, 2026	2d	5,628	—	—		Form 4 ↗
ABBV	Other A	February 18, 2026	February 20, 2026	2d	5,792	—	—		Form 4 ↗
ABBV	Other A	February 18, 2026	February 20, 2026	2d	16,290	—	—		Form 4 ↗

Filings

Filed	Form	Accession	Rows	Status	Source
March 3, 2026	Form 4	0001951400-26-000006	4	published	EDGAR ↗
February 27, 2026	Form 4	0001951400-26-000004	7	published	EDGAR ↗
February 20, 2026	Form 4	0001951400-26-000002	5	published	EDGAR ↗

Other insiders at AbbVie Inc.

Hart Brett J Director 19 rows
Donoghoe Nicholas EVP, CHIEF BUS/STRAT OFFICER 9 rows
AUSTIN ROXANNE S Director 7 rows
Davis Jennifer L. Director 7 rows
Purdue David Ryan SVP, Controller 7 rows
SALEKI-GERHARDT AZITA EVP, CHIEF OPERATIONS OFFICER 7 rows
Alpern Robert J Director 6 rows
Michael Robert A. CHIEF EXECUTIVE OFFICER 6 rows
Quaggin Susan E Director 6 rows
RAPP EDWARD J Director 6 rows

Everyone on file, with contracts and lobbying under the company's name: AbbVie Inc..

Guides for this page

What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
Rule 10b5-1 trading plans The plan must be set up when the insider has no important non-public information.
Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.

Sources and method

Official sources behind this page
Source	Filings	Rows	First filed	Newest filed	Read the originals
SEC EDGAR, Form 4	3	16	February 20, 2026	March 3, 2026	Form 4 list on EDGAR

Site built October 27, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.

Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.

Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.